10th Edition of World Congress on Infectious Diseases
June 25-27, 2026 | Barcelona, Spain
Research on Medicine and Vaccine for Covid-19
COVID-19 has claimed the lives of about 18 million people. Researchers are working around the clock to better understand, cure, and finally eradicate COVID-19 and the sickness that comes with it. WHO and its partners are dedicated to developing COVID-19 vaccines as quickly as possible while maintaining the highest safety requirements. Vaccines go through several stages of research and testing - clinical trials typically have three phases, the last of which is aimed to examine the product's capacity to protect against disease, known as effectiveness. Each phase evaluates the level of risk. Vaccines have previously been developed through a sequence of steps that can take years to complete. Given the critical need for COVID-19 vaccines, enormous financial investments and scientific collaborations are now transforming vaccine development.
- Antivirals
- Vaccines
- Clinical Trials
Francis J Castellino
University of Notre Dame, United States
Ranjan Ramasamy
ID-FISH Technology, United States
Yazdan Mirzanejad
University of British Columbia, Canada
Alexis Torres Rodriguez
NewYork-Presbyterian Queens Hospital, United States
Sasha Leibholz
New York Presbyterian Columbia/Cornell, United States
Hana Raza
Mclaren Oakland Hospital, United States
Terri Menser
Mayo Clinic, United StatesSubmit your abstract Today
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation